Vitamin D has long been accepted as a vital nutrient for bone health, with past guidelines supporting supplementation to maintain optimal levels. However, the recently updated 2024 Endocrine Society guidelines introduce a more conservative approach, shifting the focus away from widespread supplementation in healthy individuals and instead emphasizing use in high-risk populations. This chapter analyzes the key changes from the previous 2011 guidelines, including the removal of strict serum level thresholds for deficiency, revised daily intake recommendations, and screening criteria. The shift reflects growing evidence suggesting that excessive vitamin D supplementation may not provide additional health benefits and can contribute to risks such as hypercalcemia, kidney dysfunction, and eventual increased healthcare costs. The commentary explains the rationale behind said changes and the value for using evidence-based supplementation. Finally, we discuss the implications of these updated guidelines on paving clinicians’ decision-making for their patients while highlighting the need for increased awareness and adherence to ensure safe and effective vitamin D consumption.